Search

Stocks of the US medical care industry remain timely in the year 2002. There has been intense competition among managed care companies and more companies are focusing on the bottom line. These stocks are ranked favorably for investors.

Revenues and earnings continue to grow for the US medical services industry in the year 2002. Blue Cross and Blue Shield are more competitive and Medicare rates are expected to rise in the year 2003. Many of these stocks are timely for investors in the year 2002.

The medical services industry re,aims timely in the year 2002. The managed care and medicare financial environment is strong and is likely to improve. There are several timely stocks in this industry, with good appreciation potential for many.

The various sectors of the medical services industry remain timely in the year 2001, even with the weakened economy in the US. This is expected to remain the case in the year 2002, although profit margins could narrow. Investors need to consider both safety and timeliness with these stocks.

Premium rates have risen for managed care companies in the year 2001 and this is likely to continue in the future. The Patient's Bill of Rights is also pending in the Congress. Investors need to consider both safety and timeliness ratings when evaluating these securities.

Improved reimbursement rates and higher volume are helping the medical services industry remain timely in 2001, and earnings prospects remain favorable. Class action lawsuits and the patients' bill of rights are two concerns, however. There are many timely stocks in this industry for investors to consider.

Stocks of the medical care industry, health insurance plans, and other segments of the industry have risen during the first six months of the year 2000. Health maintenance organizations and managed care plans have had several legal victories in court and earnings prospects for the industry appear to be good. Investors, however, need to be selective when evaluating these stocks.

Stocks of the medical services industry have become timely in the 1990s and in the year 2000. Earnings prospects for the industry are good, but Congress may make it easier for health maintenance organizations to be sued by patients. Investors must be selective when evaluating these securities.

Medical services industry stocks have been volatile in the 4th qtr of 1999 due to possible legislative reform giving patients more rights and class action suits against health maintenance organizations. However, more money will be coming into the industry with increased Medicare reimbursements enacted by the Congress, and higher premiums and other rates are expected to aid health maintenance organization earnings. Investors must be selective with these stocks as prospects can vary due to a variety of factors.

Stocks in the medical services industry became less timely during the 3rd qtr of 1999, but future earnings prospects for these companies appear to be good in spite of Medicaid and Medicare concerns. Health maintenance organizations and managed-care companies have become more profit oriented after several years of price competition, and costs of pharmacy operations are increasing. Investors need to be selective when evaluating these stocks as future earnings prospects vary widely in this industry.

Health maintenance organizations have been controlling costs and raising premiums in 1999 in order to improve profitability after several years of price competition among managed-care companies. Price increases for pharmacy products has been one of the major industry trends in recent years and consolidation within the health care industry has been one of the methods to deal with this expense. Investors need to be selective with these stocks as their prospects can vary widely.

The stocks of medical services companies have risen, partly because of acquisitions and mergers. Continued growth is forecast for institutional pharmacies and assisted living facilities, which should experience annual growth of about 20% between 1997 and 2001. Drug companies must comply with new labelling regulations, which may affect sales of drugs intended for the elderly.

Byline: Vince Galloro The residential real estate market may have slowed to a crawl, but the property market for healthcare services is still chugging along. Healthcare real estate investment trusts, [...]

Jay Grinney, chief executive officer of rehabilitation provider HealthSouth Corp., Birmingham, Ala., acquired nearly 115,000 shares in the company's stock, according to a filing with the Securities and Exchange Commission. [...]

Byline: Jessica Zigmond With a deal to sell its outpatient rehabilitation division to Select Medical Corp. for $245 million last week, HealthSouth Corp. will focus on inpatient rehabilitation and continue [...]

Byline: Julie Piotrowski A Delaware judge may rule this week on whether to force HealthSouth Corp. to convene a shareholder meeting, which could lead the company down a path to [...]

Feds probe HealthSouth The government has launched a securities investigation of HealthSouth Corp., Birmingham, Ala. The company acknowledged being hit with a subpoena by the U.S. attorney's office for the [...]

Richard Scrushy will resume his role as Chief Executive Officer of HealthSouth Corp. and predicts the stock price will eventually rebound in the next few quarters.

Lower earnings forecasts caused HealthSouth stock prices to decrease 58% in a two-day period from $11.97 per share to $5.05 per share.

The shares of Developers Diversified Realty Corp. get a 'Long-Term Buy' rating while the shares of HealthSouth Corp. and Onyx Pharmaceutical get a rating of 'Underperform' and a 'Buy' rating respectively. The shares of American Capital Agency, American Public Education, Bankrate, and Werner Enterprises are also ranked.